Lupin Ltd signs $700 Million deal to develop anti-cancer drug
Posted by
www.biotecnika.org
Anti-cancer drug deal by Lupin and Boehringer Ingelheim worth $700 mn
In a press release on 4th September 2019, Lupin Ltd and Boehringer
Ingelheim announced a licensing, development and commercialization
agreement to develop a new drug for patients suffering from
difficult-to-treat cancers. For the $700 Million deal, Lupin will be
receiving $20 million in advance, and […]
The post Lupin Ltd signs $700 Million deal to develop anti-cancer drug
appeared first on Rasayanika .
https://www.rasayanika.com/2019/09/09/lupin-ltd-signs-700-million-deal-to-develop-anti-cancer-drug/
News
Subscribe to:
Post Comments (Atom)
Post a Comment